Další formáty:
BibTeX
LaTeX
RIS
@article{1357932,
author = {Češková, Eva},
article_location = {Abingdon},
article_number = {14},
doi = {http://dx.doi.org/10.1080/14656566.2016.1219340},
keywords = {Depressive disorder; pharmacoresistance; multimodal; multifunctional antidepressants; pharmacogenomic tests},
language = {eng},
issn = {1465-6566},
journal = {EXPERT OPINION ON PHARMACOTHERAPY},
title = {Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants},
url = {http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true},
volume = {17},
year = {2016}
}
TY - JOUR
ID - 1357932
AU - Češková, Eva
PY - 2016
TI - Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants
JF - EXPERT OPINION ON PHARMACOTHERAPY
VL - 17
IS - 14
SP - 1835-1837
EP - 1835-1837
PB - TAYLOR & FRANCIS LTD
SN - 14656566
KW - Depressive disorder
KW - pharmacoresistance
KW - multimodal
KW - multifunctional antidepressants
KW - pharmacogenomic tests
UR - http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true
L2 - http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true
N2 - Major depressive disorder (MDD) is a widespread disease, with a lifetime prevalence of 15% and an annual incidence of approximately 7%. It is associated with significant costs in quality of life, loss of work productivity, and a high risk of mortality. It is predicted to become the leading cause of disability in Western countries by 2030.
ER -
ČEŠKOVÁ, Eva. Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants. \textit{EXPERT OPINION ON PHARMACOTHERAPY}. Abingdon: TAYLOR \&{} FRANCIS LTD, 2016, roč.~17, č.~14, s.~1835-1837. ISSN~1465-6566. Dostupné z: https://dx.doi.org/10.1080/14656566.2016.1219340.
|
